These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 2987607)

  • 1. Raised sodium pump activity and a circulating sodium transport inhibitor demonstrated on red blood cells of patients with untreated essential hypertension: correlation of pump activity with potassium permeability.
    Skrabal F; Hamberger L; Cerny E; Schönegger J; Gernhold M
    Klin Wochenschr; 1985; 63 Suppl 3():117-21. PubMed ID: 2987607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epidemiological studies on electrolyte transport systems in hypertension.
    Williams RR; Hunt SC; Wu LL; Hasstedt SJ; Hopkins PN; Ash KO
    Clin Physiol Biochem; 1988; 6(3-4):136-49. PubMed ID: 3060295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against a circulating ouabain-like transport inhibitor as a cause of increased red cell sodium in essential hypertension.
    Millar JA; Bramley PM; Paulin JM; Simpson FO
    J Hypertens Suppl; 1984 Dec; 2(3):S461-3. PubMed ID: 6599699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension].
    Saitta A; Saitta MN; Messina A; Bonaiuto M; Cinquegrani M; Squadrito G; Castaldo M; Sardo A; Imbalzano E; Squadrito F
    Minerva Med; 1997; 88(7-8):275-82. PubMed ID: 9304069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and erythrocyte cations and permeability of the erythrocyte membrane to cations in essential hypertension.
    Aderounmu AF; Salako LA
    Afr J Med Med Sci; 1979; 8(1-2):45-9. PubMed ID: 122331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioactive 86rubidium influx into red blood cells in essential hypertension in relation to the plasma renin activity.
    Horký K; Schreiber V; Pribyl T
    Horm Metab Res; 1984 Jan; 16(1):41-5. PubMed ID: 6365716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potassium transport in erythrocytes from patients with gentamicin intolerance].
    Toropova FV; Smirnov AIu; Smirnova OI; Marakhova II
    Tsitologiia; 2002; 44(12):1194-8. PubMed ID: 12683330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced activity of the red-cell sodium-potassium pump in human obesity.
    De Luise M; Blackburn GL; Flier JS
    N Engl J Med; 1980 Oct; 303(18):1017-22. PubMed ID: 6252462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt sensitivity in normotensives with family history of hypertension: studies of membrane transport, intracellular electrolytes and alpha 2-adrenergic receptors.
    Skrabal F; Gruber G; Meister B; Ledochowski M; Doll P; Lang F; Cerny E
    J Hypertens Suppl; 1985 Dec; 3(3):S25-8. PubMed ID: 2856819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanism relating sodium and potassium to hypertension.
    Zhao GS; Li DY; Zhu DL; Kong DW; Qian YW; Li DP
    Ann Clin Res; 1984; 16 Suppl 43():55-61. PubMed ID: 6100156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological assessment of assays for intracellular concentration and transmembrane fluxes of sodium and potassium in erythrocytes of man.
    Lijnen P; Groeseneken D; Laermans M; Lommelen G; Piccart Y; Amery A
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):293-301. PubMed ID: 6087051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating inhibitor of sodium active transport in essential hypertension and volemic expansion].
    Devynck MA; Pernollet MG; Deray G; Rieu M; Meyer P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1691-5. PubMed ID: 3006621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of red blood cell ion transport alterations and serum lipid abnormalities in Lyon genetically hypertensive rats.
    Zicha J; Dobesová Z; Kunes J; Vincent M
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1123-8. PubMed ID: 9365824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vivo study of cation transport in essential hypertension.
    Boon NA; Aronson JK; Hallis KF; Raine AE; Grahame-Smith DD
    J Hypertens Suppl; 1984 Dec; 2(3):S457-9. PubMed ID: 6100748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered erythrocyte cation transport related to hypertension or oral contraception.
    Stokes GS; Monaghan JC; Middleton A; Gunn J; Marwood JF
    Klin Wochenschr; 1985; 63 Suppl 3():42-4. PubMed ID: 3999641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of treatment with hydrochlorothiazide on the red cell Na,K-adenosine triphosphatase in men with hypertension.
    Quintanilla AP; Finn M; Weffer MI; Del Greco F
    J Lab Clin Med; 1987 Nov; 110(5):583-7. PubMed ID: 2822824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium transport and red cell deformability.
    Wambach G; Overhoff U; Hossmann V
    Klin Wochenschr; 1985; 63 Suppl 3():35-7. PubMed ID: 2582181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.